Temptingly cheap and readily available, false pharmaceuticals are a growing, potentially lethal menace. In this issue of World Pharmaceutical Frontiers, Chris Godfrey speaks with the Medicines and Healthcare Products Regulatory Agency’s head of enforcement, Alastair Jeffrey, to find out what’s new in the war to purge falsified goods from the market and paralyse those perpetrating them.

Also in this issue: Salvatore Mascia, founder of CONTINUUS Pharmaceuticals, puts forward the case for a move towards integrated continuous manufacturing; Joel Richard, Ipsen’s senior vice-president of peptides, highlights the innovative tablet-manufacturing methods about to take the industry by storm; and Aarthi Janakiraman, analyst at Frost and Sullivan, explores how ‘smart’ packaging techniques can address compliance, sustainability and counterfeiting concerns.

Click here to view the latest digital edition of World Pharmaceutical Frontiers.